These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19785071)

  • 21. E1A-expressing adenoviral E3B mutants act synergistically with chemotherapeutics in immunocompetent tumor models.
    Cheong SC; Wang Y; Meng JH; Hill R; Sweeney K; Kirn D; Lemoine NR; Halldén G
    Cancer Gene Ther; 2008 Jan; 15(1):40-50. PubMed ID: 18034197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of human tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer.
    Murugesan SR; King CR; Osborn R; Fairweather WR; O'Reilly EM; Thornton MO; Wei LL
    Cancer Gene Ther; 2009 Nov; 16(11):841-7. PubMed ID: 19444305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of tumor selective replication-competent herpes viruses in combination with gemcitabine on pancreatic cancer.
    Watanabe I; Kasuya H; Nomura N; Shikano T; Shirota T; Kanazumi N; Takeda S; Nomoto S; Sugimoto H; Nakao A
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):875-82. PubMed ID: 17726607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncolytic adenovirus Ad5/3-delta24 and chemotherapy for treatment of orthotopic ovarian cancer.
    Raki M; Särkioja M; Desmond RA; Chen DT; Bützow R; Hemminki A; Kanerva A
    Gynecol Oncol; 2008 Jan; 108(1):166-72. PubMed ID: 17950450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virotherapeutics: conditionally replicative adenoviruses for viral oncolysis.
    Nettelbeck DM
    Anticancer Drugs; 2003 Sep; 14(8):577-84. PubMed ID: 14501378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of oncolytic herpesvirus NV1020 can be enhanced by combination with chemotherapeutics in colon carcinoma cells.
    Gutermann A; Mayer E; von Dehn-Rothfelser K; Breidenstein C; Weber M; Muench M; Gungor D; Suehnel J; Moebius U; Lechmann M
    Hum Gene Ther; 2006 Dec; 17(12):1241-53. PubMed ID: 17117895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapy.
    Fujiwara T; Kagawa S; Kishimoto H; Endo Y; Hioki M; Ikeda Y; Sakai R; Urata Y; Tanaka N; Fujiwara T
    Int J Cancer; 2006 Jul; 119(2):432-40. PubMed ID: 16477640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitisation to mitoxantrone-induced apoptosis by the oncolytic adenovirus Ad∆∆ through Bcl-2-dependent attenuation of autophagy.
    Aguirre-Hernández C; Maya-Pineda H; Millán JS; Man YKS; Lu YJ; Halldén G
    Oncogenesis; 2018 Jan; 7(1):6. PubMed ID: 29362360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenovirus-based therapy for prostate cancer.
    Ekblad M; Halldén G
    Curr Opin Mol Ther; 2010 Aug; 12(4):421-31. PubMed ID: 20677093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer gene therapy with oncolytic adenoviruses.
    Guse K; Hemminki A
    J BUON; 2009 Sep; 14 Suppl 1():S7-15. PubMed ID: 19785073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
    Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A feasibility study on gene therapy of pancreatic carcinoma with Ad-PUMA.
    Wang H; Pei W; Luan Q; Ma F; Zhou S; Zhao Z; Meng X; Zhang X; Liang X; Chen Y; Zhan Q; Lin C; Qian H; Zhao P
    Cancer Biol Ther; 2012 Jul; 13(9):712-9. PubMed ID: 22617775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer.
    Jung KH; Choi IK; Lee HS; Yan HH; Son MK; Ahn HM; Hong J; Yun CO; Hong SS
    Cancer Lett; 2017 Jun; 396():155-166. PubMed ID: 28315430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of gemcitabine and Ad5/3-Delta24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancer.
    Raki M; Kanerva A; Ristimaki A; Desmond RA; Chen DT; Ranki T; Sarkioja M; Kangasniemi L; Hemminki A
    Gene Ther; 2005 Aug; 12(15):1198-205. PubMed ID: 15800658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Past and present treatment of pancreatic adenocarcinoma: chemotherapy as a standard treatment modality.
    Abbruzzese JL
    Semin Oncol; 2002 Dec; 29(6 Suppl 20):2-8. PubMed ID: 12577227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Replication-selective oncolytic adenoviruses.
    Halldén G; Thorne SH; Yang J; Kirn DH
    Methods Mol Med; 2004; 90():71-90. PubMed ID: 14657560
    [No Abstract]   [Full Text] [Related]  

  • 37. Potent antitumor effect of neurotensin receptor-targeted oncolytic adenovirus co-expressing decorin and Wnt antagonist in an orthotopic pancreatic tumor model.
    Na Y; Choi JW; Kasala D; Hong J; Oh E; Li Y; Jung SJ; Kim SW; Yun CO
    J Control Release; 2015 Dec; 220(Pt B):766-82. PubMed ID: 26471393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of conditionally replicative adenovirus and standard chemotherapies shows synergistic antitumor effect in pancreatic cancer.
    Nelson AR; Davydova J; Curiel DT; Yamamoto M
    Cancer Sci; 2009 Nov; 100(11):2181-7. PubMed ID: 19689475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The histone deacetylase inhibitors depsipeptide and MS-275, enhance TRAIL gene therapy of LNCaP prostate cancer cells without adverse effects in normal prostate epithelial cells.
    Kasman L; Lu P; Voelkel-Johnson C
    Cancer Gene Ther; 2007 Mar; 14(3):327-34. PubMed ID: 17186014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovirus-mediated Drosophila melanogaster deoxyribonucleoside kinase mutants combined with gemcitabine harbor a safe cancer treatment profile.
    Zhu Z; Ma S; Zhao L; Sun Z; He A; Xu H; Zheng X
    Int J Oncol; 2011 Mar; 38(3):745-53. PubMed ID: 21186401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.